301 related articles for article (PubMed ID: 19085094)
1. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.
Cauli O; Rodrigo R; Llansola M; Montoliu C; Monfort P; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Metab Brain Dis; 2009 Mar; 24(1):69-80. PubMed ID: 19085094
[TBL] [Abstract][Full Text] [Related]
2. Interplay between glutamatergic and GABAergic neurotransmission alterations in cognitive and motor impairment in minimal hepatic encephalopathy.
Llansola M; Montoliu C; Agusti A; Hernandez-Rabaza V; Cabrera-Pastor A; Gomez-Gimenez B; Malaguarnera M; Dadsetan S; Belghiti M; Garcia-Garcia R; Balzano T; Taoro L; Felipo V
Neurochem Int; 2015 Sep; 88():15-9. PubMed ID: 25447766
[TBL] [Abstract][Full Text] [Related]
3. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.
Felipo V
World J Gastroenterol; 2006 Dec; 12(48):7737-43. PubMed ID: 17203513
[TBL] [Abstract][Full Text] [Related]
4. Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations.
Llansola M; Montoliu C; Cauli O; Hernández-Rabaza V; Agustí A; Cabrera-Pastor A; Giménez-Garzó C; González-Usano A; Felipo V
Metab Brain Dis; 2013 Jun; 28(2):151-4. PubMed ID: 23010935
[TBL] [Abstract][Full Text] [Related]
5. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission.
Monfort P; Muñoz MD; ElAyadi A; Kosenko E; Felipo V
Metab Brain Dis; 2002 Dec; 17(4):237-50. PubMed ID: 12602501
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.
Montoliu C; Rodrigo R; Monfort P; Llansola M; Cauli O; Boix J; Elmlili N; Agusti A; Felipo V
Metab Brain Dis; 2010 Mar; 25(1):39-48. PubMed ID: 20195723
[TBL] [Abstract][Full Text] [Related]
7. Hyperammonemia alters the mismatch negativity in the auditory evoked potential by altering functional connectivity and neurotransmission.
García-García R; Guerrero JF; Lavilla-Miyasato M; Magdalena JR; Ordoño JF; Llansola M; Montoliu C; Teruel-Martí V; Felipo V
J Neurochem; 2020 Jul; 154(1):56-70. PubMed ID: 31840253
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia.
Hernandez-Rabaza V; Cabrera-Pastor A; Taoro-Gonzalez L; Gonzalez-Usano A; Agusti A; Balzano T; Llansola M; Felipo V
J Neuroinflammation; 2016 Apr; 13(1):83. PubMed ID: 27090509
[TBL] [Abstract][Full Text] [Related]
9. NMDA receptors in hyperammonemia and hepatic encephalopathy.
Llansola M; Rodrigo R; Monfort P; Montoliu C; Kosenko E; Cauli O; Piedrafita B; El Mlili N; Felipo V
Metab Brain Dis; 2007 Dec; 22(3-4):321-35. PubMed ID: 17701332
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter receptor alterations in hepatic encephalopathy: a review.
Palomero-Gallagher N; Zilles K
Arch Biochem Biophys; 2013 Aug; 536(2):109-21. PubMed ID: 23466244
[TBL] [Abstract][Full Text] [Related]
11. Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications.
Cabrera-Pastor A; Llansola M; Montoliu C; Malaguarnera M; Balzano T; Taoro-Gonzalez L; García-García R; Mangas-Losada A; Izquierdo-Altarejos P; Arenas YM; Leone P; Felipo V
Acta Physiol (Oxf); 2019 Jun; 226(2):e13270. PubMed ID: 30830722
[TBL] [Abstract][Full Text] [Related]
12. Chronic hyperammonemia alters motor and neurochemical responses to activation of group I metabotropic glutamate receptors in the nucleus accumbens in rats in vivo.
Canales JJ; Elayadi A; Errami M; Llansola M; Cauli O; Felipo V
Neurobiol Dis; 2003 Dec; 14(3):380-90. PubMed ID: 14678755
[TBL] [Abstract][Full Text] [Related]
13. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
Rodrigo R; Felipo V
Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
[TBL] [Abstract][Full Text] [Related]
14. Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy.
Agusti A; Llansola M; Hernández-Rabaza V; Cabrera-Pastor A; Montoliu C; Felipo V
J Steroid Biochem Mol Biol; 2016 Jun; 160():88-93. PubMed ID: 26307490
[TBL] [Abstract][Full Text] [Related]
15. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo.
Cabrera-Pastor A; Taoro-Gonzalez L; Felipo V
J Neurochem; 2016 May; 137(4):539-48. PubMed ID: 26875688
[TBL] [Abstract][Full Text] [Related]
16. Hyperammonemia Enhances GABAergic Neurotransmission in Hippocampus: Underlying Mechanisms and Modulation by Extracellular cGMP.
Sancho-Alonso M; Garcia-Garcia R; Teruel-Martí V; Llansola M; Felipo V
Mol Neurobiol; 2022 Jun; 59(6):3431-3448. PubMed ID: 35320456
[TBL] [Abstract][Full Text] [Related]
17. Chronic hyperammonemia alters extracellular glutamate, glutamine and GABA and membrane expression of their transporters in rat cerebellum. Modulation by extracellular cGMP.
Cabrera-Pastor A; Arenas YM; Taoro-Gonzalez L; Montoliu C; Felipo V
Neuropharmacology; 2019 Dec; 161():107496. PubMed ID: 30641078
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
[TBL] [Abstract][Full Text] [Related]
19. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
Albrecht J; Jones EA
J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
[TBL] [Abstract][Full Text] [Related]
20. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
